Piramal Pharma

Revenue from operation grew by 11 per cent to Rs 3,202 crore versus Rs 2,889 crore in H1FY22

Piramal Pharma includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organisation (CDMO);…

The report articulates PPL’s ESG strategic and operational framework, and execution roadmap, including specific objective targets

The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment

The company plans to create two separate listed entities in financial services and pharmaceuticals

In March this year, Piramal Pharma entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an…

This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs

This deal will increase Piramal Pharma’s stake to 100 per cent in Convergence Chemicals

Piramal Pharma's Consumer Products Division announced that its Tri-Activ Disinfectant Spray for multi-surfaces is “99.9 per cent…